39
The
th Annual Meeting of March 10-11, 2018 The Endocrine Society and The Diabetes Association of the R.O.C. (Taiwan)
Masato Odawara, M.D., Ph.D. Curriculum Vitae
Affiliation: T he Department of Diabetes, Endocrinology, Metabolism and Rheumatology, Tokyo Medical University Position: Director and Professor Email: odawara@tokyo-med.ac.jp Education/ Appointments 1980 Graduated School of Medicine and Faculty of Medicine, University of Tokyo. Medical Doctor 1999 Doctor of Philosophy(PhD), University of Tokyo 1990 Research Assistant, Tokyo University Hospital 1992 Lecturer, Institute of Clinical Medicine, University of Tsukuba 1996 Clinical Lecturer of Medicine, Oxford University 2000 Director, Division of Endocrinology and Metabolism, Department of Internal Medicine, Toranomon Hospital, Federation of National Public Service Personnel Mutual Aid Associations 2004 Director and Professor of the Third Department of Internal Medicine, Tokyo Medical University Visiting Professor, Tokyo University of Pharmacy and Life Sciences 2009.9-2012.8 Executive Vice President of Tokyo Medical University Hospital 2014.4- Director and Professor of the Department of Diabetes, Endocrinology, Metabolism and Rheumatology, Tokyo Medical University 2015 Executive Director of Japan Diabetes Foundation. Director of a board of Japan Society of Adult Diseases Director of a board of Japan Society of Diabetic Complications 2018.1 President of Japan Society of Adult Diseases Research Interests Research on genetic predisposition for the development of type 2 diabetes mellitus and diabetic microvascular and macrovascular complications. Clinical trials on diabetic complications and treatment. Brief List of Publications (Selected) 1. Ueki K, Sasako T, Okazaki Y, Kato M, Okahata S, Katsuyama H, Haraguchi M, Morita A, Ohashi K, Hara K, Morise A, Izumi K, Ishizuka N, Ohashi Y, Noda M, Kadowaki T; J-DOIT3 Study Group. : Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial. Lancet Diabetes Endocrinol. 2017 Oct 24. pii: S2213-8587(17)30327-3. 2. Narisawa H, Komada Y, Miwa T, Shikuma J, Sakurai M, Odawara M, Inoue Y.: Prevalence, symptomatic features, and factors associated with sleep disturbance/insomnia in Japanese patients with type-2 diabetes. Neuropsychiatr Dis Treat. 2017 Jul 18;13:1873-1880. 3. Yamada H, Tanaka A, Kusunose K, Amano R, Matsuhisa M, Daida H, Ito M, Tsutsui H, Nanasato M, Kamiya H, Bando YK, Odawara M, Yoshida H, Murohara T, Sata M, Node K; PROLOGUE Study Investigators.: Effect of sitagliptin on the echocardiographic parameters of left ventricular diastolic function in patients with type 2 diabetes: a subgroup analysis of the PROLOGUE study. Cardiovasc Diabetol. 2017 May 11;16(1):63. 4. Seki M, Kawai Y, Ishii C, Yamanaka T, Odawara M, Inazu M.: Functional analysis of choline transporters in rheumatoid arthritis synovial fibroblasts. Mod Rheumatol. 2017 Nov;27(6):995-1003. 22
